Jefferies Financial Group Inc. Invests $4.86 Million in Zevia PBC $ZVIA

Jefferies Financial Group Inc. acquired a new position in Zevia PBC (NYSE:ZVIA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,096,590 shares of the company’s stock, valued at approximately $4,864,000. Jefferies Financial Group Inc. owned about 2.80% of Zevia PBC at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ZVIA. Divisadero Street Capital Management LP raised its stake in Zevia PBC by 90.6% during the 3rd quarter. Divisadero Street Capital Management LP now owns 6,159,362 shares of the company’s stock valued at $16,753,000 after purchasing an additional 2,928,382 shares during the last quarter. Ghisallo Capital Management LLC raised its stake in Zevia PBC by 265.1% during the 3rd quarter. Ghisallo Capital Management LLC now owns 1,100,000 shares of the company’s stock valued at $2,992,000 after purchasing an additional 798,700 shares during the last quarter. R Squared Ltd acquired a new position in Zevia PBC during the 3rd quarter valued at $36,000. TD Waterhouse Canada Inc. raised its stake in Zevia PBC by 105.2% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 122,805 shares of the company’s stock valued at $306,000 after purchasing an additional 62,959 shares during the last quarter. Finally, Strs Ohio raised its stake in Zevia PBC by 51.3% during the 3rd quarter. Strs Ohio now owns 150,500 shares of the company’s stock valued at $409,000 after purchasing an additional 51,000 shares during the last quarter. 53.21% of the stock is currently owned by institutional investors and hedge funds.

Zevia PBC Stock Performance

ZVIA opened at $1.67 on Tuesday. Zevia PBC has a twelve month low of $1.11 and a twelve month high of $3.66. The firm’s 50-day simple moving average is $1.27 and its 200-day simple moving average is $1.80. The firm has a market cap of $128.63 million, a price-to-earnings ratio of -16.71 and a beta of 0.95.

Zevia PBC (NYSE:ZVIA) last issued its quarterly earnings data on Wednesday, May 6th. The company reported ($0.03) EPS for the quarter, hitting analysts’ consensus estimates of ($0.03). Zevia PBC had a negative net margin of 4.11% and a negative return on equity of 13.43%. The firm had revenue of $46.09 million for the quarter, compared to analyst estimates of $40.97 million. As a group, sell-side analysts anticipate that Zevia PBC will post -0.1 EPS for the current fiscal year.

Analyst Ratings Changes

ZVIA has been the subject of several research analyst reports. Telsey Advisory Group cut their target price on shares of Zevia PBC from $6.00 to $5.00 and set an “outperform” rating for the company in a research note on Thursday, February 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zevia PBC in a research note on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $4.43.

Insider Transactions at Zevia PBC

In related news, CFO Girish Satya sold 41,662 shares of the stock in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $1.18, for a total value of $49,161.16. Following the sale, the chief financial officer directly owned 327,909 shares in the company, valued at $386,932.62. This trade represents a 11.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 11.11% of the company’s stock.

Zevia PBC Company Profile

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.